share_log

Oncternal Therapeutics Price Target Announced at $14.00/Share by Oppenheimer

Dow Jones Newswires ·  Apr 7, 2021 18:29

DJ Oncternal Therapeutics Initiated at Outperform by Oppenheimer

Ratings actions from Benzinga: https://www.benzinga.com/stock/ONCT/ratings

(END) Dow Jones Newswires

April 07, 2021 06:29 ET (10:29 GMT)

DJ Oncternal Therapeutics Price Target Announced at $14.00/Share by Oppenheimer

Ratings actions from Benzinga: https://www.benzinga.com/stock/ONCT/ratings

(END) Dow Jones Newswires

April 07, 2021 06:29 ET (10:29 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment